Can cannabis alter sperm and testosterone? a trial seeks answers
NCT ID NCT06755346
First seen Aug 19, 2026 · Last updated Aug 20, 2026 · Updated 1 time
Summary
This trial explores whether cannabis use changes male reproductive health, including sperm quality, testosterone levels, and genetic markers in sperm. Men who use cannabis regularly and those who don't will be randomly assigned to vape cannabis with different THC doses, a placebo, or no vaping. Researchers will measure sperm parameters, hormone levels, and stress responses to see if cannabis has a direct effect.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Cannabis (THC) in varying doses, including placebo
- What this could lead to
- If successful, this could clarify how cannabis affects male fertility, potentially informing guidance for men considering fatherhood.
- What could go wrong
- This is an early-phase trial with a small number of participants, so results may not apply broadly. Cannabis use may cause short-term side effects like anxiety or impaired coordination.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 1
The first testing in people. Mainly checks safety and dose, usually in a small group.
- Expected to start
-
Apr 2025
An estimate. Start dates often move.
- Expected to finish
-
Mar 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
21 to 64 years
- Sex
-
Male participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Regular cannabis users (21\~64 years-old men) who have used cannabis at least once a week for at least once a year or who have never used cannabis. * Willingness to abstain from using cannabis on the day of the testing session (minimum 5 hours abstinence). Exclusion Criteria: * Women * Adult men, 65 or older, and men under the age of 21 * Serious psychiatric conditions (e.g. psychosis, bipolar I and panic disorder) * Family history of psychosis * Chronic medical conditions (e.g., heart disease, diabetes) * History of adverse experiences with cannabis (e.g., anxiety and panic attacks) * Use of other illicit drugs (not cannabis) in the past 2 months * Heavy alcohol use (\>4 drinks, \>4 times/week) * Smoking/nicotine use * Infrequent cannabis use (less than once a week for only cannabis users) * BMI over 34 * Current use of corticosteroids and blood thinners
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Male reproductive problem are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Washington State University
Pullman, Washington, 99164, United States